Tumours modulate the systemic vascular response to anti‐angiogenic therapy

Toxicologic evaluation of new drug candidates routinely utilizes healthy animals. In oncology, there remains a limited understanding of the effects of novel test candidates in a diseased host. For vascular modulating agents (VMAs), an increased understanding of preclinical tumour–host interaction, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hargreaves, Adam, Barry, Simon T., Bigley, Alison, Kendrew, Jane, Price, Shirley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543901/
https://www.ncbi.nlm.nih.gov/pubmed/35152467
http://dx.doi.org/10.1002/jat.4301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543901/
https://www.ncbi.nlm.nih.gov/pubmed/35152467
http://dx.doi.org/10.1002/jat.4301

Ejemplares similares